Abstract |
Potassium Iodide is the antimycotic of choice for the treatment of cutaneous sporotrichosis, because of its efficacy, safety and low cost. We carried out a review of published studies on the benefits and adverse reactions of using SSKI (Saturated Solution Potassium Iodide) as treatment for sporotrichosis, but could not identify any well-designed clinical trails. There is an urgent need to conduct randomized double-blind placebo-controlled trials and critically assess usefulness of SSKI by using a standardize monitoring or an effective self-report system.
|
Authors | Si-Liang Xue, Li Li |
Journal | Mycopathologia
(Mycopathologia)
Vol. 167
Issue 6
Pg. 355-6
(Jun 2009)
ISSN: 1573-0832 [Electronic] Netherlands |
PMID | 19130293
(Publication Type: Journal Article, Review)
|
Chemical References |
|
Topics |
- Administration, Oral
- Humans
- Potassium Iodide
(administration & dosage, adverse effects, economics, therapeutic use)
- Randomized Controlled Trials as Topic
- Sporotrichosis
(drug therapy)
|